Ofloxacin Tablet, Coated
Product Images NDC 75834-112

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Ofloxacin (NDC 75834-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ofloxacin 01)

Chemical Structure (Ofloxacin 01)
Chemical structure of ofloxacin, illustrating its molecular framework with specific arrangements of fluorine, nitrogen, oxygen, carbon, and hydrogen atoms consistent with its quinolone antibiotic class.*
FDA Label Image

Chart (Ofloxacin 02)

Chart (Ofloxacin 02)
A line graph showing mean steady-state plasma levels of ofloxacin (400 mg dose) over 24 hours on day 5, comparing oral (PO) and intravenous (IV) administration. The y-axis displays plasma concentration in micrograms per milliliter (μg/mL), and the x-axis shows time in hours. The graph plots data points for 19 subjects, illustrating the concentration decline over time for both dosing routes.*
FDA Label Image

Principal Display Panel (200 mg Bottle Label)

Principal Display Panel (200 mg Bottle Label)
Label for Ofloxacin Tablets USP 200 mg oral coated tablets, containing 50 tablets per package. The label shows storage instructions, manufacturer information for Nivagen Pharmaceuticals, Inc., and mentions the tablet strength of 200 mg. Includes barcodes, NDC 75834-120-50, and a note for pharmacist dispensing with medication guide.*
FDA Label Image

Principal Display Panel (300 mg Bottle Label)

Principal Display Panel (300 mg Bottle Label)
Label of Ofloxacin Tablets USP 300 mg oral coated tablets. The package contains 50 tablets and is labeled for prescription use only by Nivagen Pharmaceuticals, Inc. The label includes storage instructions, manufacturer information, and barcodes.*
FDA Label Image

Principal Display Panel (400 mg Bottle Label)

Principal Display Panel (400 mg Bottle Label)
Label for Ofloxacin Tablets USP 400 mg, coated oral tablets, containing 50 tablets per package. Manufactured by Cadila Pharmaceuticals Ltd. and labeled for Nivagen Pharmaceuticals, Inc. The label includes storage instructions, prescribing information referral, and safety warnings. The NDC code 75834-112-50 is shown along with barcode and contact information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.